The present stock price for Spero Therapeutics Inc (SPRO) is $2.26. In the last trading session, the stock made a considerable jump, reaching $5.0 after an opening price of $2.26. The stock briefly fell to $5.0 before ending the session at $2.12.
Spero Therapeutics Inc experienced a somewhat steady performance in the stock market.
52-week price history of SPRO Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Spero Therapeutics Inc’s current trading price is -29.81% away from its 52-week high, while its distance from the 52-week low is 347.35%. The stock’s price range during the 52-week period has remained between $0.51 and $3.22. In the Healthcare sector, the company’s shares saw a trading volume of around 0.82 million for the day, which was evidently lower than the average daily volume of 4.45 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Spero Therapeutics Inc (SPRO) has experienced a quarterly rise of 283.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 126.36M and boasts a workforce of 32 employees.
A Closer Look at Analysts’ Ratings for Spero Therapeutics Inc
As of right now, 0 analyst is rating Spero Therapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.64, with a change in price of +1.48. Similarly, Spero Therapeutics Inc recorded 2,863,009 in trading volume during the last 100 days, posting a change of +190.30%.
Examining SPRO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SPRO stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.06.
SPRO Stock Stochastic Average
As of today, Spero Therapeutics Inc’s raw stochastic average for the last 50 days stands at 62.56%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 15.63%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 8.65% and 9.69%, respectively.
SPRO Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 72.52% this year. Over the last six months, there has been a weaker performance of 200.05%. The price of SPRO leaped by -23.13% during the last 30 days period. For the last 5-days stocks have improved 3.91%.
